510(k) Report

510(k) · Cleared

Recalled · Class I · 2019

IntraClude Intra-Aortic Occlusion Device

K163693510(k) SpecialCleared Jan 26, 201729-day reviewClass II21 CFR 870.4450Recalls 3 (1 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Edwards Lifesciences, LLC · DXC Clamp, Vascular

Cleared on Jan 26, 2017 as substantially equivalent to K132175 (Edwards Lifesciences, LLC, 2013) after a 29-day review. Its family tree reaches back 1 generation to 2013. 2 of the 2 devices in its family, counting itself, have a Class I recall. It has been recalled 3 times, including a Class I recall.

Decided
Jan 26, 2017
Review
29 days
Class
Class II
Product code
DXC
Recalls
3 (1 Class I)
Predicates
1

Its longest line of descent runs back 1 generation to K132175 (2013). No later device cites it as a predicate yet. 2 of the 2 devices in this family, counting this one, have a Class I recall.

K132175 · Edwards Lifesciences Intraclude Intra-Aortic Catheter · Edwards Lifesciences, LLC · 2013 · Class I recall20102012201420162018
  1. Root · 1 generation backK132175 Edwards Lifesciences Intraclude Intra-Aortic CatheterEdwards Lifesciences, LLC · 2013 · Recalled (Class I)
  2. This deviceK163693 IntraClude Intra-Aortic Occlusion DeviceEdwards Lifesciences, LLC · 2017

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K132175Edwards Lifesciences Intraclude Intra-Aortic CatheterEdwards Lifesciences, LLC2013Class I
0 (this device)K163693IntraClude Intra-Aortic Occlusion DeviceEdwards Lifesciences, LLC2017—
FIG. 1 — Lineage of K163693, 2013–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXC device

  1. #1 K262086 PreludeSYNC™ Radial Compression Devicescore 13.5 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K132175Edwards Lifesciences Intraclude Intra-Aortic Catheter
Summary page 4
…cclusion Device Classification Vascular Clamp Name: 21 CFR Part 870.4450, Product Code DXC, Class II Predicate Device: K132175 IntraClude™ Intra-Aortic Occlusion Device Device Description: The IntraClude Intra-Aortic Occlusion Device (model code I…
Edwards Lifesciences, LLC2013Class I

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (2 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 14, 2019Class IZ-1705-2019Device DesignPossibility of balloon rupture in intra-aortic occlusion devices. If the balloon bursts during cardiopulmonary bypass, the heart can fill and warm, the operative site may be obscured, and the device will need to be exchanged or operative…
Jan 16, 2019Class IIZ-1100-2019Process controlEdwards Lifesciences has received a limited number of customer reports regarding an inter-lumen leak between the cardioplegia lumen and pressure lumen in the device.
Mar 30, 2018Class IIZ-1929-2018Under Investigation by firmPossible leak at distal open end of the strain relief, which causes medical staff to continue adding inflation fluid to maintain balloon pressure for adequate occlusion of the ascending aorta.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K132175Edwards Lifesciences Intraclude Intra-Aortic CatheterEdwards Lifesciences, LLC · 2013 · Direct predicate · ◆ on the line of descent in FIG. 11 Class I recall

What does this lineage say?

  • Its one ancestor has a recall, Class I.

How does its category compare?

All DXC devices

DXC Clamp, Vascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · DXC

2in 2025

2007: 102008: 32009: 42010: 22011: 62012: 52013: 142014: 42015: 52016: 32017: 32018: 22019: 22020: 32021: 62022: 12023: 42024: 12025: 22026 (partial year): 4
2007high 14 (2013) · low 1 (2022)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXC

215in 2023

2007: 52 days median2008: 29 days median2009: 83 days median2011: 51 days median2012: 73 days median2013: 89 days median2014: 157 days median2015: 71 days median2016: 91 days median2017: 90 days median2020: 209 days median2021: 37 days median2023: 215 days median2026 (partial year): 125 days median
2007high 215 (2023) · low 29 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXC

2in 2023

2008: 22009: 22010: 12011: 32014: 12022: 12023: 2
2007high 3 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXC

442in 2025

2007: 2982008: 3022009: 5392010: 6002011: 6912012: 5482013: 9202014: 4942015: 3742016: 4942017: 4162018: 3912019: 3932020: 4042021: 3712022: 2732023: 6742024: 3752025: 442
2007high 920 (2013) · low 273 (2022)2025

MAUDE reports naming product code DXC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200710520298
20083292302
20094832539
20102—1600
20116513691
20125730548
201314890920
201441571494
20155710374
20163910494
20173900416
20182—0391
20192—0393
202032090404
20216370371
20221—1273
202342152674
20241—0375
20252—0442
202641250—

What is it indicated for?

The IntraClude™ Intra-Aortic Occlusion device is indicated for use in patients undergoing cardiopulmonary bypass. The IntraClude Intra-Aortic Occlusion device occludes and vents the ascending aorta when the balloon is inflated. The device’s central lumen allows delivery of cardioplegia to arrest the heart. The pressure lumen allows monitoring of the aortic root pressure.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K163693: IntraClude Intra-Aortic Occlusion Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K163693

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026